Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship between platelet reactivity inhibition and non-CABG related major bleeding in patients undergoing percutaneous coronary intervention.
Mokhtar OA, Lemesle G, Armero S, Mancini J, Bonello C, Tahirou I, Barragan P, Dignat-George F, Camoin-Jau L, Paganelli F, Bonello L. Mokhtar OA, et al. Among authors: barragan p. Thromb Res. 2010 Aug;126(2):e147-9. doi: 10.1016/j.thromres.2010.01.013. Epub 2010 Feb 2. Thromb Res. 2010. PMID: 20129650 No abstract available.
Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation.
Camenzind E, Wijns W, Mauri L, Boersma E, Parikh K, Kurowski V, Gao R, Bode C, Greenwood JP, Gershlick A, O'Neill W, Serruys PW, Jorissen B, Steg PG; PROTECT Steering Committee and Investigators. Camenzind E, et al. Am Heart J. 2009 Dec;158(6):902-909.e5. doi: 10.1016/j.ahj.2009.10.002. Am Heart J. 2009. PMID: 19958855 Clinical Trial.
Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events.
Bonello L, Paganelli F, Arpin-Bornet M, Auquier P, Sampol J, Dignat-George F, Barragan P, Camoin-Jau L. Bonello L, et al. Among authors: barragan p. J Thromb Haemost. 2007 Aug;5(8):1630-6. doi: 10.1111/j.1538-7836.2007.02609.x. Epub 2007 May 7. J Thromb Haemost. 2007. PMID: 17488353 Free article.
Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study.
Bonello L, Camoin-Jau L, Arques S, Boyer C, Panagides D, Wittenberg O, Simeoni MC, Barragan P, Dignat-George F, Paganelli F. Bonello L, et al. Among authors: barragan p. J Am Coll Cardiol. 2008 Apr 8;51(14):1404-11. doi: 10.1016/j.jacc.2007.12.044. J Am Coll Cardiol. 2008. PMID: 18387444 Free article. Clinical Trial.
A paradigm shift in anti-platelet therapy?
Bonello L, Barragan P, Paganelli F. Bonello L, et al. Among authors: barragan p. Platelets. 2008 Dec;19(8):562-4. doi: 10.1080/09537100802401118. Platelets. 2008. PMID: 19012173 Free article. No abstract available.
Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis.
Bonello L, Camoin-Jau L, Armero S, Com O, Arques S, Burignat-Bonello C, Giacomoni MP, Bonello R, Collet F, Rossi P, Barragan P, Dignat-George F, Paganelli F. Bonello L, et al. Among authors: barragan p. Am J Cardiol. 2009 Jan 1;103(1):5-10. doi: 10.1016/j.amjcard.2008.08.048. Epub 2008 Nov 13. Am J Cardiol. 2009. PMID: 19101221 Clinical Trial.
Emergence of the concept of platelet reactivity monitoring of response to thienopyridines.
Bonello L, De Labriolle A, Scheinowitz M, Lemesle G, Roy P, Steinberg DH, Pinto Slottow TL, Pakala R, Pichard AD, Barragan P, Camoin-Jau L, Dignat-George F, Paganelli F, Waksman R. Bonello L, et al. Among authors: barragan p. Heart. 2009 Aug;95(15):1214-9. doi: 10.1136/hrt.2008.152660. Epub 2009 Feb 5. Heart. 2009. PMID: 19196732 Review.
Relation of body mass index to high on-treatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention.
Bonello-Palot N, Armero S, Paganelli F, Mancini J, De Labriolle A, Bonello C, Lévy N, Maillard L, Barragan P, Dignat-George F, Camoin-Jau L, Bonello L. Bonello-Palot N, et al. Among authors: barragan p. Am J Cardiol. 2009 Dec 1;104(11):1511-5. doi: 10.1016/j.amjcard.2009.07.015. Am J Cardiol. 2009. PMID: 19932784
121 results